Ekin Özsaydı Aktaşoglu

Dr. Ekin Özsaydı Aktaşoglu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2025 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
EAEkin Özsaydı Aktaşoglu
Ekin Özsaydı Aktaşoglu
AIAsli İnCi̇
Asli İnCi̇
RÖRıdvan Murat Öktem
Rıdvan Murat Öktem
GBGürsel Bi̇bEroğlu
Gürsel Bi̇bEroğlu
IOİlYas Okur
İlYas Okur
LTLeyla Tümer
Leyla Tümer
Background/aim: Pompe disease (acid maltase deficiency, glycogen storage disease type II, OMIM #606800) is an autosomal recessive disorder characterized by lysosomal acid-α-glucosidase deficiency. The infantile-onset type of the disease is mainly characterized by cardiomegaly, hypotonia, and a high mortality rate. This study aimed to create a national consensus about infantile-onset Pompe disease (IOPD) to raise awareness among clinicians and standardize diagnosis and treatment approaches in Türkiye. Materials and methods: The Gazi University Division of Metabolic Diseases and Nutrition developed this expert opinion consensus and expanded it to include metabolism specialists across Türkiye. A systematic literature review was performed, and the Delphi method was used to evaluate the results. Results: Seventeen conclusive questions were produced about clinical presentation, diagnosis, and treatment, and 14 reached a consensus. Consensus was reached that general hypotonia is one of the most important findings, and agreement was also achieved on the starting dose of treatment for presymptomatic patients. The contributors agreed that gene therapy is a good treatment option for IOPD in the future. Conclusion: The topics related to this consensus will help physicians in Türkiye and elsewhere with high incidence rates of IOPD,especially regarding diagnosis and treatment decisions.

6 August 2024 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
EAEkin Özsaydı Aktaşoglu
Ekin Özsaydı Aktaşoglu
AKAyşe Kılıç
Ayşe Kılıç
MSmerve emecen sanli
merve emecen sanli
IIInci Inci
Inci Inci
EAEmine Aktaş
Emine Aktaş
LTLeyla Tümer
Leyla Tümer
Objectives: Glycogen storage disease type V is caused by the mutations in muscle glycogen phosphorylase gene. This is the first report which DL-3-hydroxybutyric acid was used in combination with modified Atkins diet for the treatment of a patient with glycogen storage disease type V and quadriceps femoris shear wave elastography was performed to evaluate the treatment efficacy. Case presentation: A 13-year-old girl was referred with fatigue and muscle cramps with exercise and there were no pathological findings in physical examination. Creatine kinase levels with 442 U/L. No phosphorylase enzyme activity was detected in muscle biopsy, a homozygous c.1A>G (p.M1V) pathogenic mutation was found in PYGM gene. She was started on DL-3-hydroxybutyric acid and modified Atkins diet at age 16. Her walking and stair climbing capacity increased, the need for rest during exercise decreased. The stiffness of the quadriceps femoris exhibited a reduction. Conclusions: DL-3-hydroxybutyric acid and modified Atkins diet may provide an alternative fuel and shear wave elastography may be useful in demonstrating treatment efficacy. More clinical and pre-clinical studies are obviously needed to reach more definite conclusions.

16 February 2026 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
EAEkin Özsaydı Aktaşoglu
Ekin Özsaydı Aktaşoglu
HÖHüseyin Baran Özdemir
Hüseyin Baran Özdemir
MÖMehmet Cüneyt Özmen
Mehmet Cüneyt Özmen
AİAslı İnci
Aslı İnci
IOİlYas Okur
İlYas Okur
LTLeyla Tümer
Leyla Tümer
Background: Gyrate atrophy of the choroid and retina (GACR) is a rare amino acid metabolism disorder. Night blindness, cataracts, vision loss, and impaired cognitive functions can be seen. An arginine-restricted diet, combined with pyridoxine, lysine, proline, or creatine supplementation, can be used in conjunction with treatments for ophthalmological findings. Methods: Patients followed by the Gazi University Faculty of Medicine, Department of Pediatric Metabolism and Nutrition, and Department of Ophthalmology who were genetically or biochemically diagnosed with GACR were included in the study. The patients’ medical records were retrospectively reviewed between 2000 and 2023. Results: Seven patients with a mean age of 18.08 ± 8.6 years and a mean age at diagnosis of 10.4 ± 5.6 years were included. The earliest diagnosed patient was 15 months old. All patients had high plasma ornithine levels at the time of diagnosis, and they were all started on an arginine-restricted diet. Ophthalmological treatments were decided on a patient-specific basis. Conclusions: GACR is easily recognizable, but there is still no consensus on treatment modalities. The patients primarily present with progressive ophthalmological findings. An arginine-restricted diet is combined with supplementation with pyridoxine, lysine, proline, or creatine to improve metabolic control. Ophthalmological treatments are mainly applied to reduce cystoid macular edema. Early diagnosis and early initiation of therapy should be aimed at patients, and a multidisciplinary approach should be demonstrated both in diagnosis and follow-up.

1 April 2023
Verified
Book
Open access
PDF file
YGYahya Gül
Yahya Gül
ŞKŞeyhan Kutluğ
Şeyhan Kutluğ
EDEsra Dişçi
Esra Dişçi
BYBahtınur Yener
Bahtınur Yener
MCMahmut Cesur
Mahmut Cesur
GKGülizar Koç
Gülizar Koç
Ömrünü eğitime ve tıp bilimine adamış, pediatri alanında kendi eğitimini tamamlayan ve hala sürdüren yazarlarımız ile iki yıldır süren çalışmalarımızın meyvesi olan kitabımız için çok mutluyuz. Yedi yaşından beri gece gündüz demeden çalışan, pediatri uzmanlığını ve yan dalını hakkıyla tamamlamak için çok emek harcayan arkadaşlar, tecrübelerini ve öğrendiklerini eğitime yeni başlayan meslektaşlarına aktarmak için bir kılavuz olacak bu kitabı hazırladık. Bu kitabın; pratisyen hekim, pediatri asistanları ve uzmanlarına klinik pratikte en sık karşılaşacakları hastalıkların tanısı, kliniği ve tedavisi konusunda hızlıca bilgilere ulaşabilmeleri açısından çok büyük kolaylık sağlayacağına inanıyoruz. Bu nedenle acillerde, polikliniklerde ve servislerde sıkça başvurulan bir kitap olacağını düşünüyoruz.

9 June 2026 in OSMANGAZİ JOURNAL OF MEDICINE
Verified
Journal Article
Closed access
SGSabire Gokalp
Sabire Gokalp
HBHacer Basan
Hacer Basan
EAEkin Özsaydı Aktaşoglu
Ekin Özsaydı Aktaşoglu
HAHalil Tuna Akar
Halil Tuna Akar
Inherited metabolic disorders (IMDs) are traditionally considered pediatric-onset conditions; however, an increasing number of patients are diagnosed in adolescence and adulthood, often presenting with heterogeneous and nonspecific clinical manifestations. This study aimed to describe the clinical spectrum, biochemical findings, genetic diagnoses, and management approaches in transition-age and adult patients diagnosed with IMDs. This retrospective analysis included 18 patients diagnosed with IMDs. Patients aged ≥16 years were included and defined as transition-age individuals to account for the overlap between pediatric and adult presentations. Demographic, clinical, biochemical, and genetic data were collected, and treatment strategies were recorded. Diagnostic evaluation was based on disease specific biochemical assays supplemented by molecular genetic testing. The cohort included 10 females and 8 males, with a mean age at diagnosis of 34.2 years (range: 16–61 years). The diagnostic spectrum was heterogeneous, with alkaptonuria (n = 4) as the most frequent diagnosis, followed by glycogen storage disease type V (n = 2), while the remaining disorders were individually rare. Muscle-related symptoms, including exercise intolerance, myalgia, or rhabdomyolysis, were observed in 8 patients (44.4%), and elevated creatine kinase levels were detected in 9 patients (50.0%). A definitive molecular diagnosis was established in all patients, allowing implementation of disease-specific treatment or targeted management strategies in the majority of cases. Adult-onset IMDs show marked clinical and genetic heterogeneity and frequently present with nonspecific neuromuscular or neurological findings. These results highlight the importance of considering IMDs in adult patients with unexplained multisystem involvement and underscore the role of integrated biochemical and genetic evaluation for accurate diagnosis and timely management.

13 March 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EAEkin Özsaydı Aktaşoglu
Ekin Özsaydı Aktaşoglu
EKEnes Kumcu
Enes Kumcu
SÖSelen Has Özhan
Selen Has Özhan
HAHalil Tuna Akar
Halil Tuna Akar
AOAsburçe Olgaç
Asburçe Olgaç
HKHüseyin Levent Keskin
Hüseyin Levent Keskin
This study aimed to assess obstetric healthcare providers’ awareness and knowledge of IMDs and their prenatal manifestations. Participants were surveyed using an online questionnaire about clinical and imaging features observed in fetuses and neonates with IMDs, their approach to clinical management when an IMD is suspected in the fetus, and the management of pregnant women with IMDs. 270 obstetricians participated, with a mean age of 32.5 ± 7.1 years. Most participants (81.5%) had less than 5 years of experience. The more experienced group was more likely to consider their knowledge of antenatal IMD diagnosis and follow-up to be adequate (p = 0.015). Participants in the educated group believed that IMDs could present symptoms during the intrauterine period (p = 0.003). Improving obstetricians’ awareness about IMDs to optimize prenatal counseling, referral, and perinatal planning is crucial. Theoretical and practical training in IMDs should be incorporated into obstetrics residency programs to enable timely diagnosis and early treatment initiation.